Treatment of Long COVID Symptoms Utilizing Autologous Stem Cells Following COVID-19 Infection Read more about Treatment of Long COVID Symptoms Utilizing Autologous Stem Cells Following COVID-19 Infection
A Live Recombinant Newcastle Disease Virus-vectored COVID-19 Vaccine Phase 1 Study. Read more about A Live Recombinant Newcastle Disease Virus-vectored COVID-19 Vaccine Phase 1 Study.
Seroepidemiological Investigation of Coronavirus 2019 (COVID-19) Infection in Gabon Read more about Seroepidemiological Investigation of Coronavirus 2019 (COVID-19) Infection in Gabon
RECOVER-VITAL: Platform Protocol to Measure the Effects of Antiviral Therapies on Long COVID Symptoms Read more about RECOVER-VITAL: Platform Protocol to Measure the Effects of Antiviral Therapies on Long COVID Symptoms
Evaluate the Efficacy and Safety of Azvudine in Preventing SARS-Cov-2 Infection in Household Contacts of Covid-19 Read more about Evaluate the Efficacy and Safety of Azvudine in Preventing SARS-Cov-2 Infection in Household Contacts of Covid-19
SARS-CoV-2 CTLS for Mild to Moderate COVID-19 Disease Read more about SARS-CoV-2 CTLS for Mild to Moderate COVID-19 Disease
A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01C and SCTV01E in Population Aged ≥12 Years Previously Fully Vaccinated With Inactivated COVID-19 Vaccine Read more about A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01C and SCTV01E in Population Aged ≥12 Years Previously Fully Vaccinated With Inactivated COVID-19 Vaccine
Collection of SARS CoV-2 (COVID-19) Virus Secretions and Serum for Countermeasure Development Read more about Collection of SARS CoV-2 (COVID-19) Virus Secretions and Serum for Countermeasure Development
A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01C in Population Aged ≥18 Years and Previously Fully Vaccinated With COVID-19 Vaccine Read more about A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01C in Population Aged ≥18 Years and Previously Fully Vaccinated With COVID-19 Vaccine
A Study to Evaluate the Immunogenicity and Safety of Two Recombinant Protein COVID-19 Vaccines in Population Aged ≥18 Years as Booster Vaccines Read more about A Study to Evaluate the Immunogenicity and Safety of Two Recombinant Protein COVID-19 Vaccines in Population Aged ≥18 Years as Booster Vaccines
